Q3 2013 13F Holders as of 30 Sep 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
3,187,525
-
Share change
-
-500,857
-
Total reported value
-
$230,105,655
-
Price per share
-
$72.21
-
Number of holders
-
13
-
Value change
-
-$36,130,561
-
Number of buys
-
3
-
Number of sells
-
6
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q3 2013
As of 30 Sep 2013,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,187,525 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, Citadel Advisors LLC, Retirement Systems of Alabama, PDT Partners, LLC, Zurcher Kantonalbank (Zurich Cantonalbank), BANK OF MONTREAL /CAN/, DIAM Co., Ltd., HARTFORD INVESTMENT MANAGEMENT CO, AZZAD ASSET MANAGEMENT INC /ADV, and Veritable, L.P..
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.